A contemporary evidence basis for neoadjuvant chemotherapy in upfront resectable pancreatic adenocarcinoma: a systematic review of the literature

by David P. Stonko, MD, MS, Jin He, MD, PhD, Lei Zheng, MD, PhD, Alex B. Blair, MD
Published 2020-03-01

Clinicopathological features and surgical outcomes of resected functional pancreatic neuroendocrine tumors: a single institution experience

by Ammar A. Javed, MD, Alina Hasanain, MD, Aleezay Haider, George Jones, BS, Zunaira N. Javed, Kevin Soares, MD, Richard A. Burkhart, MD, John L. Cameron, MD, FACS, Matthew J. Weiss, MD, FACS, Christopher L. Wolfgang, MD, PhD, FACS, Jin He, MD, PhD, FACS
Published 2019-06-01

Response to Commentary on ‘“Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multi...

by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)
Published 2023-06-01

Geographic variation in attitudes regarding management of locally advanced pancreatic cancer

by Logan R. McNeil, BA, Alex B. Blair, MD, Robert W. Krell, MD, Chunmeng Zhang, MD, Aslam Ejaz, MD, MPH, Vincent P. Groot, MD, PhD, Georgios Gemenetzis, MD, James C. Padussis, MD, Massimo Falconi, MD, Christopher L. Wolfgang, MD, PhD, Matthew J. Weiss, MD, Chandrakanth Are, MD, MBA, Jin He, MD, PhD, Bradley N. Reames, MD, MS
Published 2022-10-01

Response to Commentary “Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?”

by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)
Published 2023-03-01

Gastric cancer following pancreaticoduodenectomy: Experience from a high-volume center and review of existing literature

by Michael Johannes Pflüger, MD, Matthäus Felsenstein, MD, Ryan Schmocker, MD, Laura DeLong Wood, MD, PhD, Ralph Hruban, MD, Kohei Fujikura, MD, PhD, Noah Rozich, MD, Floortje van Oosten, MD, Matthew Weiss, MD, William Burns, MD, Jun Yu, MD, PhD, John Cameron, MD, Johann Pratschke, MD, Christopher Lee Wolfgang, MD, PhD, Jin He, MD, PhD, Richard Andrew Burkhart, MD
Published 2020-10-01

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy

by Zhi Cheng, MD, MPH, Lauren M. Rosati, BS, Linda Chen, MD, Omar Y. Mian, MD, PhD, Yilin Cao, MD, Marta Villafania, BS, Minoru Nakatsugawa, PhD, Joseph A. Moore, PhD, Scott P. Robertson, PhD, Juan Jackson, BS, Amy Hacker-Prietz, PA-C, Jin He, MD, PhD, Christopher L. Wolfgang, MD, PhD, Matthew J. Weiss, MD, Joseph M. Herman, MD, MS, Amol K. Narang, MD, Todd R. McNutt, PhD
Published 2018-10-01

Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic

by Daniel Li, MD, MA, Angela Y. Jia, MD, PhD, Jane Zorzi, BS, Paige Griffith, MSN, AG-ACNP, BSN, Amy K. Kim, MD, Doan Dao, MD, Robert A. Anders, MD, PhD, Christos Georgiades, MD, PhD, Robert P. Liddell, MD, Kelvin Hong, MD, Nilofer S. Azad, MD, Won Jin Ho, MD, Marina Baretti, MD, Eric Christenson, MD, Azarakhsh Baghdadi, MD, MAS, Ihab R. Kamel, MD, PhD, Jeffrey Meyer, MD, Elie Ghabi, MD, Richard A. Burkhart, MD, Kelly Lafaro, MD, MPH, Jin He, MD, Chris Shubert, MD, Mark Yarchoan, MD
Published 2022-12-01